| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |